Dean Mary Klotman, MD, marks the beginning of Women's History Month and encourages viewers to check out resources about some of the extraordinary women who have helped to shape Duke. She also highlights an important Duke study about tumor biology, and tells of the Chan Zuckerberg Initiative that unites Duke, UNC, and NC State to develop tools to map and manipulate kinases - enzymes that play a key role in many diseases.

A perplexing problem for people with recurring urinary tract infections (UTIs) is persistent pain, even after antibiotics have successfully cleared the bacteria. Now Duke Health researchers have identified the likely cause - an overgrowth of nerve cells in the bladder.

In this month’s EDI Spotlight, Madhav Swaminathan, MD shares how he became involved with a group focused on increasing inclusion of neurodiversity, a disability that he says is often hidden yet deserves more attention in EDI work.

As part of the university's centennial celebration, the Duke Cancer Institute hosted the 2nd annual MaryAnn Black Distinguished Health Equity Symposium in honor of the late MaryAnn Black.

A principal link in the life of this university.” That is how former Duke University President Richard H. Broadhead described Mary Duke Biddle Trent Semans.

Duke University, in collaboration with the University of North Carolina-Chapel Hill and ​​​NC​​ State University, has received a three-year, $3 million grant from the Chan​ ​Zuckerberg Initiative (

Duke University and North Carolina Central University recently received the National Institutes of Health (NIH) Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in

Duke University Hospital focuses on an often-overlooked issue in gun violence: creating a path forward for gunshot wound survivors.

Women are less likely than men to receive life-saving CPR and defibrillator help during cardiac arrest – a problem that persists regardless of neighborhood diversity.

An internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, Dr. Robert Califf now heads the U.S. Food and Drug Administration.